ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email!
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 Published on July 2014
Report Summary Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, 'Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014" provides data on the Neuromyelitis Optica (Devic's Syndrome) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuromyelitis Optica (Devic's Syndrome). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuromyelitis Optica (Devic's Syndrome). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Content Table of Contents Table of Contents 2 Introduction 6 Neuromyelitis Optica (Devic's Syndrome) 6 Report Guidance 6
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 1/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials 28 Prominent Drugs 30 Latest Clinical Trials News on Neuromyelitis Optica (Devic's Syndrome) 31 Apr 24, 2014: Alexion Initiates Multinational Registration Trials of Eculizumab as a Potential Treatment for Patients with Relapsing Neuromyelitis Optica and Refractory Generalized Myasthenia Gravis 31 Clinical Trial Profiles 33 Clinical Trial Overview of Top Companies 33 Alexion Pharmaceuticals, Inc. 33 Clinical Trial Overview of Alexion Pharmaceuticals, Inc. 33 Shire Plc 34 Clinical Trial Overview of Shire Plc 34 F. Hoffmann-La Roche Ltd. 35 Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35 Takeda Pharmaceutical Company Limited 36 Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36 Shenzhen Beike Biotechnology Co., Ltd. 37 Clinical Trial Overview of Shenzhen Beike Biotechnology Co., Ltd. 37 Bionure Farma, S.L. 38 Clinical Trial Overview of Bionure Farma, S.L. 38 Alnylam Pharmaceuticals, Inc. 39 Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 39 Clinical Trial Overview of Top Institutes / Government 40 Johns Hopkins University 40 Clinical Trial Overview of Johns Hopkins University 40 Mayo Clinic 41 Clinical Trial Overview of Mayo Clinic 41 National Neuroscience Institute 42 Clinical Trial Overview of National Neuroscience Institute 42
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 2/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! University of California, San Francisco 43 Clinical Trial Overview of University of California, San Francisco 43 University of Texas Southwestern Medical Center at Dallas 44 Clinical Trial Overview of University of Texas Southwestern Medical Center at Dallas 44 State University of New York at Buffalo 45 Clinical Trial Overview of State University of New York at Buffalo 45 Kobe University 46 Clinical Trial Overview of Kobe University 46 Northwestern University 47 Clinical Trial Overview of Northwestern University 47 Sun Yat-sen University 48 Clinical Trial Overview of Sun Yat-sen University 48 National Institute of Neurological Disorders and Stroke 49 Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 49 Five Key Clinical Profiles 50 Appendix 132 Abbreviations 132 Definitions 132 Research Methodology 133 Secondary Research 133 About GlobalData 134 Contact Us 134 Disclaimer 134 Source 134 List of Tables
Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Region, 2014* 7 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14 Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17 Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Phase, 2014* 21 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 3/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2014* 33 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014* 34 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 35 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014* 36 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Beike Biotechnology Co., Ltd., 2014* 37 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Bionure Farma, S.L., 2014* 38 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2014* 39 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 40 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 41 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Neuroscience Institute, 2014* 42 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 43 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas Southwestern Medical Center at Dallas, 2014* 44 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by State University of New York at Buffalo, 2014* 45 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2014* 46 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 47 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 48 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 49 List of Figures
Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14 Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 4/7
ReportLinker
Find Industry reports, Company profiles and Market Statistics
>> Get this Report Now by email! Proportion of Neuromyelitis Optica (Devic's Syndrome) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22 Neuromyelitis Optica (Devic's Syndrome) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28 Neuromyelitis Optica (Devic's Syndrome) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30 GlobalData Methodology 133
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 5/7
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ
Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information Please verify that the product information is correct and select the format(s) you require. Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014
Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 500.00
Quantity: _____
Site License--USD 5 000.00
Quantity: _____
Corporate License--USD 7 500.00
Quantity: _____
Contact Information Please enter all the information below in BLOCK CAPITALS
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
First Name:
_____________________________ Last Name: __________________________________
Email Address:
__________________________________________________________________________
Job Title:
__________________________________________________________________________
Organization:
__________________________________________________________________________
Address:
__________________________________________________________________________
City:
__________________________________________________________________________
Postal / Zip Code:
__________________________________________________________________________
Country:
__________________________________________________________________________
Phone Number:
__________________________________________________________________________
Fax Number:
__________________________________________________________________________
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 6/7
Find Industry reports, Company profiles and Market Statistics
ReportLinker
>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card
Card Number: ______________________________________________
Expiry Date
__________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer
Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check
UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms
Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
Neuromyelitis Optica (Devic's Syndrome) Global Clinical Trials Review, H2, 2014 (From Issuu)
Page 7/7